Clinical Trials in Georgia

Showing 2201-2220 of 16,324 trials

Prostate Active Surveillance Study

NCT00756665

The Prostate Active Surveillance Study (PASS) is a research study for men who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance is defined as close monitoring of prostate cancer with the offer of treatment if there are changes in test results. This study seeks to discover markers that will identify cancers that are more aggressive from those tumors that grow slowly.

Prostatic Neoplasms

University of Washington3,000 participantsStarted Jul 2008

San Francisco, California, United States • San Francisco, California, United States • Stanford, California, United States +8 more locations

Active Not RecruitingPhase 365 miles

Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)

NCT06486441

The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer who have received prior treatment with platinum-based chemotherapy and immunotherapy, versus the treatment of physician's choice (TPC). The primary objectives of this study are to evaluate the effect of SG compared to TPC on progression-free survival (PFS) as assessed by blinded independent central review (BICR) and overall survival (OS).

Endometrial Cancer

Gilead Sciences640 participantsStarted Aug 2024

Little Rock, Arkansas, United States • Duarte, California, United States • La Jolla, California, United States +186 more locations

Prostate Active Surveillance Study

Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)

Find Trials by Condition in Georgia

Assessment of CCM in HF With Higher Ejection Fraction

Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC

Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV

A Study of Cytisinicline for Smoking Cessation in Adult Smokers

PKU Protein Requirements

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears

An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)

VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)

Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma

A Study of DM005 in Patients With Advanced Solid Tumors

Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 Expression

IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma

A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

A Study of DM002 in Patients With Advanced Solid Tumors